Faculty Profiles - MARUYAMA, Shoichi

Papers - MARUYAMA, Shoichi

Division display 201 - 220 of about 410 ／ All the affair displays >>

Rationale and design of oBservational clinical Research In chronic kidney disease patients with renal anemia: renal proGnosis in patients with Hyporesponsive anemia To Erythropoiesis-stimulating agents, darbepoetiN alfa (BRIGHTEN Trial) (vol 22, pg 78, 2018) Open Access

Kato, H; Nangaku, M; Hirakata, H; Wada, T; Hayashi, T; Sato, H; Yamazaki, Y; Masaki, T; Kagimura, T; Yamamoto, H; Hase, H; Kamouchi, M; Imai, E; Mizuno, K; Iwasaki, M; Akizawa, T; Tsubakihara, Y; Maruyama, S; Narita, I

CLINICAL AND EXPERIMENTAL NEPHROLOGY Vol. 22 ( 1 ) page： 85 - 86 2018.2

Effect of dietary energy and polymorphisms in BRAP and GHRL on obesity and metabolic traits. Reviewed

Imaizumi Takahiro, Ando Masahiko, Nakatochi Masahiro, Yasuda Yoshinari, Honda Hiroyuki, Kuwatsuka Yachiyo, Kato Sawako, Kondo Takaaki, Iwata Masamitsu, Nakashima Toru, Yasui Hiroshi, Takamatsu Hideki, Okajima Hiroshi, Yoshida Yasuko, Maruyama Shoichi

Obes Res Clin Pract Vol. 12 ( 1 ) page： 39 - 48 2018.1

Urinary and circulating levels of the anti-angiogenic isoform of vascular endothelial growth factor-A in patients with chronic kidney disease Reviewed

Kikuchi Ryosuke, Yasuda Yoshinari, Nakatochi Masahiro, Shibata Yohei, Hara Toshiaki, Suzuki Atsuo, Imaizumi Takahiro, Suzuki Susumu, Ishii Hideki, Takeshita Kyosuke, Matsushita Tadashi, Maruyama Shoichi, Murohara Toyoaki

Clin Chim Acta Vol. 475 page： 102 - 108 2017.12

The Japanese Histologic Classification and T-score in the Oxford Classification system could predict renal outcome in Japanese IgA nephropathy patients Reviewed

Kaihan Ahmad Baseer, Yasuda Yoshinari, Katsuno Takayuki, Kato Sawako, Imaizumi Takahiro, Ozeki Takaya, Hishida Manabu, Nagata Takanobu, Ando Masahiko, Tsuboi Naotake, Maruyama Shoichi

CLINICAL AND EXPERIMENTAL NEPHROLOGY Vol. 21 ( 6 ) page： 986 - 994 2017.12

Mizoribine therapy combined with steroids and mizoribine blood concentration monitoring for idiopathic membranous nephropathy with steroid-resistant nephrotic syndrome Reviewed Open Access

Saito Takao, Iwano Masayuki, Matsumoto Koichi, Mitarai Tetsuya, Yokoyama Hitoshi, Yorioka Noriaki, Nishi Shinichi, Yoshimura Ashio, Sato Hiroshi, Ogahara Satoru, Sasatomi Yoshie, Kataoka Yasufumi, Ueda Shiro, Koyama Akio, Maruyama Shoichi, Nangaku Masaomi, Imai Enyu, Matsuo Seiichi, Tomino Yasuhiko

CLINICAL AND EXPERIMENTAL NEPHROLOGY Vol. 21 ( 6 ) page： 961 - 970 2017.12

Seasonal proteinuria changes in IgA nephropathy patients after proteinuria remission Reviewed Open Access

Inagaki Koji, Yasuda Yoshinari, Ando Masahiko, Kaihan Ahmad Baseer, Hachiya Asaka, Ozeki Takaya, Hishida Manabu, Imaizumi Takahiro, Katsuno Takayuki, Kato Sawako, Tsuboi Naotake, Maruyama Shoichi

PLOS ONE Vol. 12 ( 11 ) page： e0187607 2017.11

Association between kidney function and genetic polymorphisms in atherosclerotic and chronic kidney diseases: A cross-sectional study in Japanese male workers Reviewed Open Access

Kubo Yoko, Imaizumi Takahiro, Ando Masahiko, Nakatochi Masahiro, Yasuda Yoshinari, Honda Hiroyuki, Kuwatsuka Yachiyo, Kato Sawako, Kikuchi Kyoko, Kondo Takaaki, Iwata Masamitsu, Nakashima Toru, Yasui Hiroshi, Takamatsu Hideki, Okajima Hiroshi, Yoshida Yasuko, Maruyama Shoichi

PLOS ONE Vol. 12 ( 10 ) page： e0185476 2017.10

Efficacy of urinary midkine as a biomarker in patients with acute kidney injury Reviewed Open Access

Hayashi Hiroki, Sato Waichi, Kosugi Tomoki, Nishimura Kunihiro, Sugiyama Daisuke, Asano Naoko, Ikematsu Shinya, Komori Kimihiro, Nishiwaki Kimitoshi, Kadomatsu Kenji, Matsuo Seiichi, Maruyama Shoichi, Yuzawa Yukio

Clin Exp Nephrol Vol. 21 ( 4 ) page： 597 - 607 2017.8

Randomized controlled trial for assessment of Internet of Things system to guide intensive glucose control in diabetes outpatients: Nagoya Health Navigator Study protocol Reviewed Open Access

Onoue Takeshi, Goto Motomitsu, Kobayashi Tomoko, Tominaga Takashi, Ando Masahiko, Honda Hiroyuki, Yoshida Yasuko, Tosaki Takahiro, Yokoi Hisashi, Kato Sawako, Maruyama Shoichi, Arima Hiroshi

Nagoya J Med Sci Vol. 79 ( 3 ) page： 323 - 329 2017.8

Mesangial proliferative glomerulonephritis in murine malaria parasite, Plasmodium chabaudi AS, infected NC mice Reviewed Open Access

Yashima Akihito, Mizuno Masashi, Yuzawa Yukio, Shimada Koki, Suzuki Norihiko, Tawada Hideo, Sato Waichi, Tsuboi Naotake, Maruyama Shoichi, Ito Yasuhiko, Matsuo Seiichi, Ohno Tamio

Clin Exp Nephrol Vol. 21 ( 4 ) page： 589 - 596 2017.8

Apoptosis inhibitor of macrophage ameliorates fungus-induced peritoneal injury model in mice Reviewed Open Access

Tomita Takako, Arai Satoko, Kitada Kento, Mizuno Masashi, Suzuki Yasuhiro, Sakata Fumiko, Nakano Daisuke, Hiramoto Emiri, Takei Yoshifumi, Maruyama Shoichi, Nishiyama Akira, Matsuo Seiichi, Miyazaki Toru, Ito Yasuhiko

Sci Rep Vol. 7 ( 1 ) page： 6450 2017.7

Long-term renal survival of gamma 3-heavy chain deposition disease: a case report Reviewed Open Access

Katsuno Takayuki, Mizuno Shige, Mabuchi Masatsuna, Tsuboi Naotake, Komatsuda Atsushi, Maruyama Shoichi

BMC NEPHROLOGY Vol. 18 ( 1 ) page： 239 2017.7

Association of interactions between dietary salt consumption and hypertension-susceptibility genetic polymorphisms with blood pressure among Japanese male workers Reviewed

Imaizumi Takahiro, Ando Masahiko, Nakatochi Masahiro, Maruyama Shoichi, Yasuda Yoshinari, Honda Hiroyuki, Kuwatsuka Yachiyo, Kato Sawako, Kondo Takaaki, Iwata Masamitsu, Nakashima Toru, Yasui Hiroshi, Takamatsu Hideki, Okajima Hiroshi, Yoshida Yasuko, Matsuo Seiichi

Clin Exp Nephrol Vol. 21 ( 3 ) page： 457 - 464 2017.6

Sodium chloride promotes tissue inflammation via osmotic stimuli in subtotal-nephrectomized mice Reviewed Open Access

Sakata Fumiko, Ito Yasuhiko, Mizuno Masashi, Sawai Akiho, Suzuki Yasuhiro, Tomita Takako, Tawada Mitsuhiro, Tanaka Akio, Hirayama Akiyoshi, Sagara Akihiro, Wada Takashi, Maruyama Shoichi, Soga Tomoyoshi, Matsuo Seiichi, Imai Enyu, Takei Yoshifumi

LABORATORY INVESTIGATION Vol. 97 ( 4 ) page： 432 - 446 2017.4

Growth Factor Midkine Promotes T-Cell Activation through Nuclear Factor of Activated T Cells Signaling and Th1 Cell Differentiation in Lupus Nephritis Reviewed Open Access

Masuda Tomohiro, Maeda Kayaho, Sato Waichi, Kosugi Tomoki, Sato Yuka, Kojima Hiroshi, Kato Noritoshi, Ishimoto Takuji, Tsuboi Naotake, Uchimura Kenji, Yuzawa Yukio, Maruyama Shoichi, Kadomatsu Kenji

Am J Pathol Vol. 187 ( 4 ) page： 740 - 751 2017.4

Postpartum atypical hemolytic uremic syndrome with complement factor H mutation complicated by reversible cerebrovascular constriction syndrome successfully treated with eculizumab Reviewed

Yamaguchi Makoto, Hori Mayuko, Hiroshi Nagaya, Maruyama Shoichi

Thromb Res Vol. 151 page： 79 - 81 2017.3

Complement component 5 promotes lethal thrombosis Reviewed Open Access

Mizuno Tomohiro, Yoshioka Kengo, Mizuno Masashi, Shimizu Mie, Nagano Fumihiko, Okuda Tomoyuki, Tsuboi Naotake, Maruyama Shoichi, Nagamatsu Tadashi, Imai Masaki

SCIENTIFIC REPORTS Vol. 7 page： 42714 2017.2

High Levels of Soluble C5b-9 Complex in Dialysis Fluid May Predict Poor Prognosis in Peritonitis in Peritoneal Dialysis Patients Reviewed Open Access

Mizuno Masashi, Suzuki Yasuhiro, Higashide Keiko, Sei Yumi, Iguchi Daiki, Sakata Fumiko, Horie Masanobu, Maruyama Shoichi, Matsuo Seiichi, Morgan B. Paul, Ito Yasuhiko

PLOS ONE Vol. 12 ( 1 ) page： e0169111 2017.1

The Type of Vascular Access and the Incidence of Mortality in Japanese Dialysis Patients Reviewed

Ozeki Toshikazu, Shimizu Hideaki, Fujita Yoshiro, Inaguma Daijo, Maruyama Shoichi, Ohyama Yukako, Minatoguchi Shun, Murai Yukari, Terashita Maho, Tagaya Tomoki

Internal Medicine Vol. 56 ( 5 ) page： 481 - 485 2017

Language：English Publishing type：Research paper (scientific journal) Publisher：The Japanese Society of Internal Medicine

Objective The National Kidney Foundation (NKF) Kidney Disease Outcome Quality Initiative (KDOQI) guidelines have recommended the use of arteriovenous fistula (AVF) at the initiation of dialysis. However, there are significant differences in the dialysis environments of Japan and the United States, and there are few people who receive hemodialysis via a central venous catheter (CVC) in Japan. The aim of the present study was to examine the association between the type of vascular access at the initiation of dialysis and the incidence of mortality in Japan. Methods This study was a prospective, multicenter, cohort study. The data was collected by the Aichi Cohort study of Prognosis in Patients newly initiated into dialysis (AICOPP) in which 18 Japanese tertiary care centers participated. The present study enrolled 1,524 patients who were newly introduced to dialysis (the patients started maintenance dialysis between October 2011 and September 2013). After excluding 183 patients with missing data, 1,341 patients were enrolled. The Cox proportional hazards model was used to evaluate mortality based on the type of vascular access. The types of vascular access were divided into four categories: AVF, arteriovenous graft (AVG), CVC changed to AVF during the course (CAVF), CVC changed to AVG during the course (CAVG). Results A multivariate analysis revealed that AVG, CAVF and CAVG were associated with a higher risk of mortality in comparison to AVF [hazard ratio (HR), 1.60; p=0.048; HR, 2.26; p=0.003; and HR, 2.45; p=0.001, respectively]. Conclusion The research proved that the survival rate among patients in whom hemodialysis was initiated with AVF was significantly higher than that in patients in whom hemodialysis was initiated with AVG or CVC.

DOI： 10.2169/internalmedicine.56.7563

Web of Science

PubMed

CiNii Research

Single-dose Rituximab Therapy for Refractory Idiopathic Membranous Nephropathy: A Single-center Experience Reviewed

Katsuno Takayuki, Ozaki Takenori, Kim Hangsoo, Kato Noritoshi, Suzuki Yasuhiro, Akiyama Shinichi, Ishimoto Takuji, Kosugi Tomoki, Tsuboi Naotake, Ito Yasuhiko, Maruyama Shoichi

Intern Med Vol. 56 ( 13 ) page： 1679 - 1686 2017

Authorship：Last author Language：English Publishing type：Research paper (scientific journal) Publisher：The Japanese Society of Internal Medicine

To date, a recognized treatment for refractory membranous nephropathy (MN) has not been established. Recently, several reports have indicated the efficacy of rituximab as a novel treatment option. However, only a few published accounts exist of rituximab therapy for idiopathic MN (IMN) in the Asian population. We present the cases of three IMN patients who were treated with single-dose rituximab after they showed no response to conventional therapies, including corticosteroids, cyclosporine, cyclophosphamide, mizoribine, and mycophenolate mofetil. Although one case showed no response, a complete or incomplete remission was achieved in the other two cases. Rituximab may therefore be a beneficial treatment option for IMN.

DOI： 10.2169/internalmedicine.56.7908

Web of Science

PubMed

CiNii Research

　 PREV - NEXT 　

<MARUYAMA, Shoichi>

Papers - MARUYAMA, Shoichi